# ATGL From iWAT and BAT Is Crucial for Cardiac Remodeling and Metabolism After Myocardial Ischemia/Reperfusion

**Authors:** Heba Zabri, Alisa Ucar, Luzhou Wang, Simone Gorressen, Richard Kretschmer, Daniel Gorski, Tobias Lautwein, Mirela Balan, Stefan Lehr, Andre Heinen, Axel Gödecke, Jens W. Fischer, Katharina Bottermann

PMC · DOI: 10.1002/cph4.70106 · 2026-02-04

## TL;DR

This study shows that ATGL in white and brown fat is essential for protecting the heart after a heart attack and reperfusion.

## Contribution

The study reveals a depot- and time-specific role of adipocyte ATGL in cardiac ischemia/reperfusion injury.

## Key findings

- iatATGL-KO mice showed worsened cardiac function and increased scar formation after I/R.
- ATGL deficiency reduced BAT activation and adiponectin secretion, contributing to worse outcomes.
- Remote myocardium in iatATGL-KO mice exhibited higher oxygen consumption and mechanical stress.

## Abstract

Adipose tissue ATGL has emerged as an important player in cardiovascular disease. Myocardial infarction is accompanied by sympathetic stimulation and activation of white adipose tissue and peripheral lipolysis. We therefore investigate here the role of adipocyte ATGL in a murine model of cardiac ischemia and reperfusion (I/R) by using an inducible, adipocyte specific KO of ATGL (iatATGL‐KO). Notably this led to successfully inhibited lipolysis during cardiac ischemia, and KO mice exhibited aggravated cardiac dysfunction and enhanced scar formation after 28 days I/R. This phenotype went along with multiple structural and molecular alterations mainly in the subcutaneous white adipose tissue depot (iWAT) and brown adipose tissue (BAT). The iatATGL‐KO mainly reduced BAT activation as well as adiponectin‐secretion. In the heart spatial transcriptomic analysis suggested higher mechanical stress in the remote myocardium, which went along with higher oxygen consumption rates (OCR) and higher dependency on glucose as substrate after 24 h I/R. Taken together, iatATGL‐KO hearts after I/R seem to be affected in multiple ways, such as a reduction in cardioprotective factors from iWAT and BAT as well as an oxygen wasting effect in the remote zone of the heart, which contribute to the worse outcome. This indicates a time and depot‐specific role of adipocyte ATGL in cardiac ischemia and reperfusion injury.

Cardiac I/R activates adipose tissue. iatATGL‐KO increases adipocyte size and reduces lipogenesis in WAT, induces whitening and inflammation in BAT, and reduces circulating NEFA and adiponectin levels. As a consequence, cardiac function is reduced, scar formation enhanced, and remote myocardium shows elevated mechanical stress and oxygen consumption.

## Linked entities

- **Genes:** PNPLA2 (patatin like domain 2, triacylglycerol lipase) [NCBI Gene 57104]
- **Diseases:** myocardial infarction (MONDO:0005068)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Plin1 (perilipin 1) [NCBI Gene 103968] {aka 6030432J05Rik, Peri, Plin}, Cidea (cell death-inducing DNA fragmentation factor, alpha subunit-like effector A) [NCBI Gene 12683], Lipe (lipase E, hormone sensitive type) [NCBI Gene 16890] {aka 4933403G17Rik, HSL, REH}, Cpt1b (carnitine palmitoyltransferase 1b, muscle) [NCBI Gene 12895] {aka Cpt1, Cpt1-m, Cpti, Cpti-m, M-cpti}, Blnk (B cell linker) [NCBI Gene 17060] {aka BASH, Bca, Ly-57, Ly57, Lyw-57, SLP-65}, Slc2a1 (solute carrier family 2 (facilitated glucose transporter), member 1) [NCBI Gene 20525] {aka GT1, Glut-1, Glut1, M100200, Rgsc200}, Prdm16 (PR domain containing 16) [NCBI Gene 70673] {aka 5730557K01Rik, csp1, mel1}, Nppa (natriuretic peptide type A) [NCBI Gene 230899] {aka ANP, Anf, CDD, Pnd}, Nppb (natriuretic peptide type B) [NCBI Gene 18158] {aka BNF, BNP, Iso-ANP}, Serpine1 (serine (or cysteine) peptidase inhibitor, clade E, member 1) [NCBI Gene 18787] {aka PAI-1, PAI1, Planh1}, Mgll (monoglyceride lipase) [NCBI Gene 23945] {aka Magl, Mgl}, Baat (bile acid-Coenzyme A: amino acid N-acyltransferase) [NCBI Gene 12012] {aka BAT}, Srebf1 (sterol regulatory element binding transcription factor 1) [NCBI Gene 20787] {aka ADD1, SREBP1, bHLHd1}, Cox8b (cytochrome c oxidase subunit 8B) [NCBI Gene 12869] {aka Cox8h, CoxVIII-H}, Dgat2 (diacylglycerol O-acyltransferase 2) [NCBI Gene 67800] {aka 0610010B06Rik, ARAT, DGAT-2}, Adrb3 (adrenergic receptor, beta 3) [NCBI Gene 11556] {aka Adrb-3, beta 3-AR}, Lep (leptin) [NCBI Gene 16846] {aka ob, obese}, Hc (hemolytic complement) [NCBI Gene 15139] {aka C5, C5a, He, Hfib2}, Adipoq (adiponectin, C1Q and collagen domain containing) [NCBI Gene 11450] {aka 30kDa, APN, Acdc, Acrp30, Ad, Adid}, Lgals3 (lectin, galactose binding, soluble 3) [NCBI Gene 16854] {aka GBP, L-34, Mac-2, gal3}, Pnpla2 (patatin-like phospholipase domain containing 2) [NCBI Gene 66853] {aka 0610039C21Rik, 1110001C14Rik, Atgl, TTS-2.2}, Xirp2 (xin actin-binding repeat containing 2) [NCBI Gene 241431] {aka 2310003D02Rik, 2310008C07Rik, A530024P18Rik, Cmya3, Gm352, Xin2}, Abhd5 (abhydrolase domain containing 5) [NCBI Gene 67469] {aka 1300003D03Rik, 2010002J10Rik, CGI-58, IECN5, NCIE2}, Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, Ucp1 (uncoupling protein 1 (mitochondrial, proton carrier)) [NCBI Gene 22227] {aka Slc25a7, Ucp}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Des (desmin) [NCBI Gene 13346], Ankrd1 (ankyrin repeat domain 1) [NCBI Gene 107765] {aka Alrp, CARP, Crap, MARP1}
- **Diseases:** ischemic (MESH:D002545), obesity (MESH:D009765), INF (MESH:D007238), cardiac remodeling (MESH:D020257), cardiac fibrosis (MESH:D005355), Diabetes (MESH:D003920), heart failure (MESH:D006333), cardiovascular disease (MESH:D002318), Cardiac Ischemia (MESH:D007511), /R (MESH:C580424), necrotic (MESH:D009336), Myocardial Ischemia (MESH:D017202), Cardiac infarct (MESH:D009203), Cardiac I/R (MESH:D015427), Cardiac Dysfunction (MESH:D006331), inflammation (MESH:D007249)
- **Chemicals:** 2,3-butanedione monoxime (MESH:C004717), heparin (MESH:D006493), SDS (MESH:D012967), FA (MESH:D005227), Alexa Fluor 488 (MESH:C000711379), calcium (MESH:D002118), bromophenol blue (MESH:D001978), Atglistatin (MESH:C585749), agarose (MESH:D012685), OCT (MESH:C051883), Methanol (MESH:D000432), 2,3,5-Triphenyltetrazolium Chloride (MESH:C009591), Glucose (MESH:D005947), HCl (MESH:D006851), etomoxir (MESH:C054207), TBS (MESH:D013725), polyethylene (MESH:D020959), MgCl2 (MESH:D015636), UK 5099 (MESH:C043654), DMEM (-), catecholamines (MESH:D002395), glutamine (MESH:D005973), antimycin A (MESH:D000968), carnitine (MESH:D002331), Iso (MESH:D007545), FFA (MESH:D005230), isopentane (MESH:C067038), Alexa Fluor 647 (MESH:C569686), Flux (MESH:C040639), EDTA (MESH:D004492), NaHCO3 (MESH:D017693), ethanol (MESH:D000431), CL-316,243 (MESH:C076126), tamoxifen (MESH:D013629), FCCP (MESH:D002259), Carbon (MESH:D002244), sucrose (MESH:D013395), rotenone (MESH:D012402), glycerol (MESH:D005990), Buprenorphine (MESH:D002047), Oxygen (MESH:D010100), taurine (MESH:D013654), xylazine (MESH:D014991), palmitate (MESH:D010168), 4-hydroxytamoxifen (MESH:C016601), polyacrylamide (MESH:C016679), DTT (MESH:D004229), aldosterone (MESH:D000450), PBS (MESH:D007854), Evans Blue (MESH:D005070), paraffin (MESH:D010232), water (MESH:D014867), KCl (MESH:D011189), isoflurane (MESH:D007530), NaCl (MESH:D012965), Hepes (MESH:D006531), triglyceride (MESH:D014280), TCC (MESH:C009540)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12872207/full.md

---
Source: https://tomesphere.com/paper/PMC12872207